A metastatic hepatoma model of rats using the 13762-MAT-B-III cell line: Basic characteristics and potential as a tool for interventional oncology experiments

Anticancer Research

Volumn 35, Issue 3, 2015, Pages 1333-1338

  Choi, Jin Woo ^a   Kim, Hyo Cheol ^a   Baek, Song Yi ^a   Ryu, Young Jin ^a   Chung, Jin Wook ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

13762 MAT B III; Animal model; Liver; Metastasis; Transarterial embolization

Indexed keywords

13762 MAT B III CELL LINE; ADENOCARCINOMA CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL EMBOLISM; AUTOPSY; BREAST CANCER CELL LINE; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE SEVERITY; HISTOLOGY; LIVER CELL CARCINOMA; METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM TUMOR; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE; TUMOR CELL INOCULATION; TUMOR GROWTH; TUMOR SEEDING; TUMOR VOLUME; ANIMAL; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION; DISEASE MODEL; FISCHER 344 RAT; HUMAN; LIVER NEOPLASMS; MALE; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE MODELS, ANIMAL; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; RATS, INBRED F344;

EID: 84925012827     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kim HC, Chung JW, Choi SH, Im SA, Yamasaki Y, Jun S, Jae HJ and Park JH: Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model. Cardiovasc Intervent Radiol 35: 168-175, 2012.
2. Sheu AY, Zhang Z, Omary RA and Larson AC: MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model. Invest Radiol 48: 492-499, 2013.
3. Lee KH, Liapi EA, Cornell C, Reb P, Buijs M, Vossen JA, Ventura VP and Geschwind JF: Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol 33: 576-582, 2010.
4. Gordon AC, Lewandowski RJ, Salem R, Day DE, Omary RA and Larson AC: Localized hyperthermia with iron oxide-doped yttrium microparticles: steps toward image-guided thermoradio-therapy in liver cancer. J Vasc Interv Radiol 25: 397-404, 2014.
5. Zhang Y, White SB, Nicolai JR, Zhang Z, West DL, Kim DH, Goodwin AL, Miller FH, Omary RA and Larson AC: Multimo-dality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. Radiology 271: 721-729, 2014.
6. Cho HR, Choi JW, Kim HC, Song YS, Kim GM, Son KR and Chung JW: Sprague-Dawley rats bearing McA-RH7777 cells for study of hepatoma and transarterial chemoembolization. Anticancer Res 33: 223-230, 2013.
7. Li X, Wang YX, Zhou X, Guan Y and Tang C: Catheterization of the hepatic artery via the left common carotid artery in rats. Cardiovasc Intervent Radiol 29: 1073-1076, 2006.
8. Choi JW, Kim H, Kim HC, Lee Y, Kwon J, Yoo RE, Cho HR, Choi SH and Chung JW: Blood oxygen level-dependent MRI for evaluation of early response of liver tumors to chemo-embolization: an animal study. Anticancer Res 33: 1887-1892, 2013.
9. Chen J, Sheu AY, Li W, Zhang Z, Kim DH, Lewandowski RJ, Omary RA, Shea LD and Larson AC: Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors. J Control Release 184: 10-17, 2014.
10. Wang GZ, Fang ZT, Zhang W, Qu XD, Qian S, Liu R and Wang JH: Increased metastatic potential of residual carcinoma after transarterial embolization in rat with McA-RH7777 hepatoma. Oncol Rep 31: 95-102, 2014.
11. Buijs M, Geschwind JF, Syed LH, Ganapathy-Kanniappan S, Kunjithapatham R, Wijlemans JW, Kook Kwak B, Ota S and Vali M: Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies. J Vasc Interv Radiol 23: 1685-1691, 2012.
12. Kan Z, Kobayashi S, Phongkitkarun S and Charnsangavej C: Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model. Radiology 237: 144-150, 2005.
13. Neri A, Welch D, Kawaguchi T and Nicolson GL: Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 68: 507-517, 1982.
14. Song YS, Park CM, Lee SM, Park SJ, Cho HR, Choi SH, Lee JM, Kiefer B and Goo JM: Reproducibility of histogram and texture parameters derived from intravoxel incoherent motion diffusion-weighted MRI of FN13762 rat breast Carcinomas. Anticancer Res 34: 2135-2144, 2014.
15. Park CM, Goo JM, Lee HJ, Kim MA, Kim HC, Kim KG, Lee CH and Im JG: FN13762 murine breast cancer: region-by-region correlation of first-pass perfusion CT indexes with histologic vascular parameters. Radiology 251: 721-730, 2009.
16. Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ and Francis IR: T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 230: 637-644, 2004.
17. Thompson SM, Callstrom MR, Knudsen B, Anderson JL, Butters KA, Grande JP, Roberts LR and Woodrum DA: AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohisto-chemistry. Cardiovasc Intervent Radiol 36: 198-203, 2013.